Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-07

Clinical Trial Update: Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial [Phase 2]

View source ↗

Summary

Explorative Phase 2 trial evaluating hyperbaric oxygen therapy to reduce lymphedema after breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Danish Cancer Society | Conditions: Secondary Lymphedema | Phase 2 | Status: UNKNOWN